|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | A61K 38/17 | (2006.01) |
| C07K 14/71 | (2006.01) | ||
| G01N 33/49 | (2006.01) | ||
| A61P 7/00 | (2006.01) | ||
| A61P 7/06 | (2006.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Patento numeris | 3227675 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15865213.1 |
| Europos patento paraiškos padavimo data | 2015-12-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-10-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-03-15 |
| (46) | Apibrėžties vertimo paskelbimo data | 2023-06-12 |
| (86) | Numeris | PCT/US2015/063595 |
| Data | 2015-12-03 |
| (87) | Numeris | WO 2016/090077 |
| Data | 2016-06-09 |
| (30) | Numeris | Data | Šalis |
| 201462086977 P | 2014-12-03 | US | |
| 201462088478 P | 2014-12-05 | US | |
| 201562153872 P | 2015-04-28 | US | |
| 201562173782 P | 2015-06-10 | US | |
| 201562218728 P | 2015-09-15 | US |
| (72) |
ATTIE, Kenneth M. , US
ROVALDI, Christopher , US
LAADEM, Abderrahmane , US
|
| (73) |
Celgene Corporation ,
86 Morris Avenue, Summit, NJ 07901,
US
Acceleron Pharma Inc. , 128 Sidney Street, Cambridge, MA 02139, US |
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Aktivino ActRII antagonistai ir naudojimas mielodisplastiniam sindromui gydyti |
| ACTIVIN-ACTRII ANTAGONISTS AND USES FOR TREATING MYELODYSPLASTIC SYNDROME |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2024-11-06 | 10 | 231.00 EUR |
| 2025-12-03 |